The estimated Net Worth of Dane Andreeff is at least $12.8 Thousand dollars as of 14 December 2023. Mr Andreeff owns over 5,000 units of Helius Medical Technologies Inc stock worth over $10,303 and over the last 7 years he sold HSDT stock worth over $0. In addition, he makes $2,500 as Pres and CEO & Director at Helius Medical Technologies Inc.
Sign up
Mr Andreeff HSDT stock SEC Form 4 insiders trading
Mr has made over 17 trades of the Helius Medical Technologies Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently he bought 5,000 units of HSDT stock worth $40,500 on 14 December 2023.
The largest trade he's ever made was buying 255,101 units of Helius Medical Technologies Inc stock on 22 December 2017 worth over $499,998. On average, Mr trades about 36,843 units every 70 days since 2017. As of 14 December 2023 he still owns at least 12,879 units of Helius Medical Technologies Inc stock.
You can see the complete history of Mr Andreeff stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Dane Carl Andreeff biography
Dane Carl Andreeff is the Pres, CEO & Director at Helius Medical Technologies Inc.
What is the salary of Mr Andreeff?
As the Pres and CEO & Director of Helius Medical Technologies Inc, the total compensation of Mr Andreeff at Helius Medical Technologies Inc is $2,500. There are 1 executives at Helius Medical Technologies Inc getting paid more, with Jeffrey S. Mathiesen CPA, CPA having the highest compensation of $5,000.
How old is Mr Andreeff?
Mr Andreeff is 55, he's been the Pres and CEO & Director of Helius Medical Technologies Inc since . There are 1 older and 1 younger executives at Helius Medical Technologies Inc. The oldest executive at Helius Medical Technologies Inc is Jeffrey S. Mathiesen CPA, CPA, 60, who is the CFO & Treasurer.
What's Mr Andreeff's mailing address?
Dane's mailing address filed with the SEC is C/O HELIUS MEDICAL TECHNOLOGIES, INC., 642 NEWTOWN YARDLEY ROAD, SUITE 100, NEWTOWN, PA, 18940.
Insiders trading at Helius Medical Technologies Inc
Over the last 9 years, insiders at Helius Medical Technologies Inc have traded over $0 worth of Helius Medical Technologies Inc stock and bought 1,827,117 units worth $3,547,767 . The most active insiders traders include Dane Andreeff, Blane Walter, and Philippe Deschamps. On average, Helius Medical Technologies Inc executives and independent directors trade stock every 121 days with the average trade being worth of $58,628. The most recent stock trade was executed by Dane Andreeff on 14 December 2023, trading 5,000 units of HSDT stock currently worth $40,500.
What does Helius Medical Technologies Inc do?
helius medical technologies, inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. the company's product is portable neuromodulation stimulator (pons), a medical device in canada for the treatment of chronic balance deficit due to mild-to-moderate traumatic brain injury. its pons device treats neurostimulation of cranial nerves via the tongue to restore lost function. the company is headquartered in newtown, pennsylvania.
What does Helius Medical Technologies Inc's logo look like?
Complete history of Mr Andreeff stock trades at Helius Medical Technologies Inc
Helius Medical Technologies Inc executives and stock owners
Helius Medical Technologies Inc executives and other stock owners filed with the SEC include:
-
Jeffrey S. Mathiesen CPA, CPA,
CFO & Treasurer -
Dane Carl Andreeff,
Pres, CEO & Director -
Dr. Brian W. Bapty Ph.D.,
VP of Strategy and Bus. Devel. -
Dr. Antonella Favit-Van Pelt M.D., Ph.D.,
Chief Medical Officer -
Frederick Fantazzia,
VP of Sales & Marketing- North America -
Joyce N La Viscount,
CFO and COO -
Mitch E Tyler,
Director -
Edward M Straw,
-
Jonathan Sackier,
Chief Medical Officer -
Thomas E Griffin,
Director -
Huaizheng Peng,
Director -
Jennifer Laux,
Chief Commercial Officer -
Philippe Deschamps,
President and CEO -
Brian Bapty,
Vice President -
Pelt Antonella R. Favit Van,
Chief Medical Officer -
Paul Buckman,
-
Blane Walter,
-
Jeffrey S Mathiesen,
CFO and Treasurer -
Sherrie L Perkins,